-
Je něco špatně v tomto záznamu ?
Antibiotic consumption and its influence on the resistance in Enterobacteriaceae
MH. Sedláková, K. Urbánek, V. Vojtová, H. Suchánková, P. Imwensi, M. Kolář,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14398
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
BioMedCentral
od 2008-12-01
BioMedCentral Open Access
od 2008
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Medline Complete (EBSCOhost)
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
Springer Nature OA/Free Journals
od 2008-12-01
PubMed
25027417
DOI
10.1186/1756-0500-7-454
Knihovny.cz E-zdroje
- MeSH
- aminoglykosidy terapeutické užití MeSH
- antibakteriální látky terapeutické užití MeSH
- beta-laktamy terapeutické užití MeSH
- Enterobacter cloacae účinky léků izolace a purifikace fyziologie MeSH
- enterobakteriální infekce farmakoterapie mikrobiologie MeSH
- Escherichia coli účinky léků izolace a purifikace fyziologie MeSH
- fluorochinolony terapeutické užití MeSH
- Klebsiella pneumoniae účinky léků izolace a purifikace fyziologie MeSH
- lidé MeSH
- lineární modely MeSH
- mikrobiální testy citlivosti MeSH
- mnohočetná bakteriální léková rezistence účinky léků MeSH
- Proteus mirabilis účinky léků izolace a purifikace fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Increasing bacterial resistance to antibiotics is one of the most serious problems in current medicine. An important factor contributing to the growing prevalence of multiresistant bacteria is application of antibiotics. This study aimed at analyzing the development of resistance of Enterobacteriaceae to selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the University Hospital Olomouc and assessing the effect of selection pressure of these antibiotics. METHODS: For the period between 1 January 2000 and 31 December 2011, resistance of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and aminoglycosides was retrospectively studied. For the assessment of selection pressure of antibiotics, a parameter of defined daily dose in absolute annual consumption (DDDatb) based on the ATC/DDD classification and in relative annual consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was used. The relationship between frequency of strains resistant to a particular antibiotic and antibiotic consumption was assessed by linear regression analysis using Spearman's correlation. The level of statistical significance was set at p < 0.05. RESULTS: A total of 113,027 isolates from the Enterobacteriaceae family were analyzed. There was a significant effect of selection pressure of the primary antibiotic in the following cases: piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella pneumoniae and Escherichia coli and amikacin in Escherichia coli and Enterobacter cloacae. Also, there was significant correlation between resistance to ceftazidime and consumption of piperacillin/tazobactam in Klebsiella pneumoniae and Escherichia coli. No relationship was found between consumption of third- and fourth-generation cephalosporins and resistance to ceftazidime or between fluoroquinolone consumption and resistance to ciprofloxacin. CONCLUSION: The study showed the effects of both direct and indirect selection pressure on increasing resistance to gentamicin, amikacin, piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was found between resistance to fluoroquinolones and consumption of either primary or secondary antibiotics, we assume that the increasing resistance to fluoroquinolones is probably due to circulation of resistance genes in the bacterial population and that this resistance was not affected by reduced use of these antibiotics.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014137
- 003
- CZ-PrNML
- 005
- 20190902152557.0
- 007
- ta
- 008
- 150420s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1756-0500-7-454 $2 doi
- 035 __
- $a (PubMed)25027417
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Htoutou Sedláková, Miroslava $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic. miroslava.htoutou@seznam.cz. $7 xx0134388
- 245 10
- $a Antibiotic consumption and its influence on the resistance in Enterobacteriaceae / $c MH. Sedláková, K. Urbánek, V. Vojtová, H. Suchánková, P. Imwensi, M. Kolář,
- 520 9_
- $a BACKGROUND: Increasing bacterial resistance to antibiotics is one of the most serious problems in current medicine. An important factor contributing to the growing prevalence of multiresistant bacteria is application of antibiotics. This study aimed at analyzing the development of resistance of Enterobacteriaceae to selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the University Hospital Olomouc and assessing the effect of selection pressure of these antibiotics. METHODS: For the period between 1 January 2000 and 31 December 2011, resistance of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and aminoglycosides was retrospectively studied. For the assessment of selection pressure of antibiotics, a parameter of defined daily dose in absolute annual consumption (DDDatb) based on the ATC/DDD classification and in relative annual consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was used. The relationship between frequency of strains resistant to a particular antibiotic and antibiotic consumption was assessed by linear regression analysis using Spearman's correlation. The level of statistical significance was set at p < 0.05. RESULTS: A total of 113,027 isolates from the Enterobacteriaceae family were analyzed. There was a significant effect of selection pressure of the primary antibiotic in the following cases: piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella pneumoniae and Escherichia coli and amikacin in Escherichia coli and Enterobacter cloacae. Also, there was significant correlation between resistance to ceftazidime and consumption of piperacillin/tazobactam in Klebsiella pneumoniae and Escherichia coli. No relationship was found between consumption of third- and fourth-generation cephalosporins and resistance to ceftazidime or between fluoroquinolone consumption and resistance to ciprofloxacin. CONCLUSION: The study showed the effects of both direct and indirect selection pressure on increasing resistance to gentamicin, amikacin, piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was found between resistance to fluoroquinolones and consumption of either primary or secondary antibiotics, we assume that the increasing resistance to fluoroquinolones is probably due to circulation of resistance genes in the bacterial population and that this resistance was not affected by reduced use of these antibiotics.
- 650 _2
- $a aminoglykosidy $x terapeutické užití $7 D000617
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x účinky léků $7 D024901
- 650 _2
- $a Enterobacter cloacae $x účinky léků $x izolace a purifikace $x fyziologie $7 D016972
- 650 _2
- $a enterobakteriální infekce $x farmakoterapie $x mikrobiologie $7 D004756
- 650 _2
- $a Escherichia coli $x účinky léků $x izolace a purifikace $x fyziologie $7 D004926
- 650 _2
- $a fluorochinolony $x terapeutické užití $7 D024841
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Klebsiella pneumoniae $x účinky léků $x izolace a purifikace $x fyziologie $7 D007711
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Proteus mirabilis $x účinky léků $x izolace a purifikace $x fyziologie $7 D011513
- 650 _2
- $a beta-laktamy $x terapeutické užití $7 D047090
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Urbánek, Karel, $d 1969- $7 xx0078289
- 700 1_
- $a Vojtová, Vladimíra $7 xx0301884
- 700 1_
- $a Jurečková, Hana $7 xx0250629
- 700 1_
- $a Imwensi, Peter $7 _AN074508
- 700 1_
- $a Kolář, Milan, $d 1964- $7 jn20010310083
- 773 0_
- $w MED00165970 $t BMC research notes $x 1756-0500 $g Roč. 7, č. - (2014), s. 454
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25027417 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20190902152926 $b ABA008
- 999 __
- $a ok $b bmc $g 1071718 $s 897015
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 7 $c - $d 454 $i 1756-0500 $m BMC research notes $n BMC Res Notes $x MED00165970
- GRA __
- $a NT14398 $p MZ0
- LZP __
- $a Pubmed-20150420